.jpg)
The Blueprint
Strategic, science-driven, and built to win
PRE-CONSTRUCTION
Laying the Foundation
Launch of Decker’s Blueprint: a mission to end nonsense mutations and skip faulty exons.
Urgency: Time is muscle — every day matters.
Donors join a winning team moving fast with guided direction and measurable impact.
FOUNDATION & FRAMING
Raising the Walls
-
Gala & Flex Challenge: Raised $400,000+ and national awareness.
-
Strong framework: community support, policy asks, and partnerships to accelerate progress.
MECHANICAL & EXTERIOR
Translational Research
-
Invest in cutting-edge therapies that turn genetic stop signs into green lights so the full protein is made and muscles stay strong.
-
Exon skipping for rare exons (Duchenne specific)
-
Goal: $3,000,000 for basic & translational research.
INTERIOR FINISHING
-
Support new approaches to bring therapies into and through the clinic faster.
-
Strategic trials designed to expand access, refine delivery, and get treatments to kids.
-
Goal: $1,500,000 for clinical trial advancement.
Clinical Advancement
Blueprint Complete
FINALIZATION
-
Deliver a transformative treatment that not only helps Duchenne but also 3–4 million people with nonsense mutations in other rare diseases.
-
Goal: $500,000 for advocacy and building partnerships that accelerate cures.
THE TOTAL GOAL: $5 MILLION Over Two Years
-
Your investment drives a full build: from research labs to clinical trials to families everywhere. Together, we are not waiting — we are winning.
